ARTH insider filings

Arch Therapeutics, Inc. — 21 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-08. Screen ARTH transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ARTH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Arch Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-09-084Norchi Terrence W — PRESIDENT AND CHIEF EXECUTIVE, DirectorPurchase (P): 6,862 @ $0.28 · Grant/award (A): 13,724 (derivative)EDGAR
2023-09-084Hicks Laurence — DirectorPurchase (P): 10,292 @ $0.28 · Grant/award (A): 20,584 (derivative)EDGAR
2023-09-084ABRAMS MICHAEL S — CHIEF FINANCIAL OFFICERPurchase (P): 10,292 @ $0.28 · Grant/award (A): 20,584 (derivative)EDGAR
2022-11-104Fish Guy L. — DirectorGrant/award (A): 250,000 (derivative) @ $0EDGAR
2022-11-104Hicks Laurence — DirectorGrant/award (A): 250,000 (derivative) @ $0EDGAR
2022-11-104Yrigoyen Dan — VICE PRESIDENT, SALESGrant/award (A): 500,000 (derivative) @ $0EDGAR
2022-11-104Norchi Terrence W — PRESIDENT AND CHIEF EXECUTIVEGrant/award (A): 1,250,000 (derivative) @ $0EDGAR
2022-11-104ABRAMS MICHAEL S — CHIEF FINANCIAL OFFICERGrant/award (A): 900,000 (derivative) @ $0EDGAR
2022-11-104DHILLON PUNIT — DirectorGrant/award (A): 250,000 (derivative) @ $0EDGAR
2022-07-084Norchi Terrence W — PRESIDENT AND CHIEF EXECUTIVEGrant/award (A): 72,435 · Grant/award (A) · Grant/award (A): 482,897 (derivative)EDGAR
2022-07-084Hicks Laurence — DirectorGrant/award (A): 108,652 · Grant/award (A): 36,000 (derivative) · Grant/award (A): 724,346 (derivative)EDGAR
2022-07-084ABRAMS MICHAEL S — CHIEF FINANCIAL OFFICERGrant/award (A): 108,652 · Grant/award (A): 36,000 (derivative) · Grant/award (A): 724,346 (derivative)EDGAR
2022-06-094Yrigoyen Dan — VICE PRESIDENT, SALESGrant/award (A): 150,000 (derivative) @ $0EDGAR
2022-01-044Fish Guy L. — DirectorGrant/award (A): 250,000 (derivative) @ $0EDGAR
2021-10-134Hicks Laurence — DirectorGrant/award (A): 250,000 (derivative) @ $0EDGAR
2021-10-014Yrigoyen Dan — Vice President, SalesGrant/award (A): 200,000 (derivative) @ $0EDGAR
2021-10-014Norchi Terrence W — President, CEO and Director, DirectorGrant/award (A): 1,000,000 (derivative) @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0EDGAR
2021-10-014ABRAMS MICHAEL S — Chief Financial OfficerGrant/award (A): 350,000 (derivative) @ $0EDGAR
2021-10-014DHILLON PUNIT — DirectorGrant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2021-10-014SULAT JAMES R — DirectorGrant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2021-08-114Yrigoyen Dan — Vice President, SalesGrant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR

Recent 8-K events — Arch Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-05-238-K1.03 — Bankruptcy or Receivership
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
4.01 — Changes in Registrant's Certifying Accountant
8.01 — Other Events
EDGAR
2025-02-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-01-238-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-078-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-048-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-09-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-09-198-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-09-138-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-208-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARTH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs